In kidneys, AcSDKP also restored the diabetes-suppressed FGFR1 and P-MAP4K4 levels and the diabetes-induced TGFβ1 and TGFβ2 expression (Supplementary Figure S6). Here, TMSB4X is linked to diabetes mellitus.